February 2022

Ferrer Announces Distribution Agreement With United Therapeutics for Treprostinil Inhalation Solution for Pulmonary Hypertension Associated With Interstitial Lung Disease

PH-ILD is a rare, serious, and progressive illness without an approved treatment in Europe and many other parts of the world Ferrer BARCELONA, Spain, Feb. 28, 2022 (GLOBE NEWSWIRE) — In the run up to Rare Disease Day, which is held on 28 February, International pharmaceutical company Ferrer has strengthened its focus on

>

Civil groups march in Taipei, demand truth about 228 Incident

Hundreds of people took to the streets of Taipei on Monday in a commemorative march on the 75th anniversary of the 228 Incident, and they demanded to know the truth about the violent crackdown on the civilian uprisings in 1947.”We remember the past, no…

>